Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Controlled Trial Investigating the Use of PuraBond® (3-D Matrix) in Transoral Resections of Primary Oral or Oropharyngeal Mucosal Lesions

NCT05773781 is registered in ClinicalTrials.gov with University of Liverpool as lead sponsor.

NCT NCT05773781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05773781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Controlled Trial Investigating the Use of PuraBond® (3-D Matrix) in Transoral Resections of Primary Oral or Oropharyngeal Mucosal Lesions
Lead sponsor
University of Liverpool
Phase
Not applicable
Overall status
Completed
Start date
October 16, 2023
Completion date
August 30, 2024
Enrollment
73 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhage, hemostatics, oral cavity, oropharynx, pain